# FDA Inspection 913034 - ProPharma Group - February 06, 2015

Source: https://www.keypedia.com/records/fda_inspections/propharma-group/2370d8ef-2874-4e28-9ffa-6da324909c35
Source feed: FDA_Inspections

> FDA Inspection 913034 for ProPharma Group on February 06, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 913034
- Company Name: ProPharma Group
- Inspection Date: 2015-02-06
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 745964 - 2011-09-21](https://www.keypedia.com/records/fda_inspections/propharma-group/8d0131d3-24bc-4da2-beb4-a6a5bd77c163)
- [FDA Inspection 613009 - 2009-09-21](https://www.keypedia.com/records/fda_inspections/propharma-group/b5a9f0e3-126e-4a24-bc96-4fb790022fdc)

Company: https://www.keypedia.com/companies/propharma-group/2868b7ec-04a0-42c2-a8f3-58ba9efb4f27

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c